Clinical Trial Update: PP-Gemcitabine & External Beam Radiation-Sarcomas [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluating PP-Gemcitabine in combination with External Beam Radiation for sarcoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sarcoma

Drugs mentioned

• PP-Gemcitabine (gemcitabine prodrug)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Sarcoma | Phase 1 | Status: COMPLETED